Free Trial
OTCMKTS:TSNDF

TerrAscend 8/7/2025 Earnings Report

TerrAscend logo
$0.55 +0.04 (+8.76%)
As of 08/8/2025 03:59 PM Eastern

TerrAscend EPS Results

Actual EPS
-$0.03
Consensus EPS
-$0.02
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

TerrAscend Revenue Results

Actual Revenue
$65.01 million
Expected Revenue
$64.87 million
Beat/Miss
Beat by +$140.00 thousand
YoY Revenue Growth
N/A

TerrAscend Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

TerrAscend Earnings Headlines

Q2 EPS Estimates for TerrAscend Cut by Ventum Cap Mkts
Q2 EPS Estimates for TerrAscend Increased by Atb Cap Markets
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.
TerrAscend Reports Second Quarter 2025 Financial Results
See More TerrAscend Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like TerrAscend? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TerrAscend and other key companies, straight to your email.

About TerrAscend

TerrAscend (OTCMKTS:TSNDF) cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. The company produces and distributes hemp-derived wellness products to retail locations; and manufactures vaporizables, concentrates, topicals, tinctures and edibles. It also operates retail dispensaries under the Apothecarium and State Flower brand names. The company was incorporated in 2017 and is headquartered in Mississauga, Canada.

View TerrAscend Profile

More Earnings Resources from MarketBeat